Aspen Pharmacare Holdings Ltd Capital Reinvestment Ratio
Aspen Pharmacare Holdings Ltd capital reinvestment ratio. Aspen Pharmacare Holdings Ltd (APN) has a Capital Reinvestment Ratio of 0.32x as of December 2025, meaning it reinvests 0% of its operating cash flow (ZAC3.58 Billion) in capital expenditures (ZAC1.13 Billion). Check Aspen Pharmacare Holdings Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Aspen Pharmacare Holdings Ltd (2003–2025)
Capital reinvestment ratio of Aspen Pharmacare Holdings Ltd from 2003 to 2025. This chart tracks Aspen Pharmacare Holdings Ltd's Capital Reinvestment Ratio across 23 annual periods. Also explore how fast is Aspen Pharmacare Holdings Ltd growing its equity to track the company's year-over-year net asset growth rate.
Aspen Pharmacare Holdings Ltd Capital Reinvestment Ratio by Year (2003–2025)
Aspen Pharmacare Holdings Ltd capital reinvestment ratio by year from 2003 to 2025. For the full cash flow conversion analysis, see APN cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (ZAC) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.98x | ZAC5.16 Billion | ZAC5.05 Billion | ▲ +10.2% |
| 2024 | 0.89x | ZAC6.22 Billion | ZAC5.54 Billion | ▲ +54.3% |
| 2023 | 0.58x | ZAC5.52 Billion | ZAC3.18 Billion | ▲ +14.8% |
| 2022 | 0.50x | ZAC5.37 Billion | ZAC2.70 Billion | ▼ -0.2% |
| 2021 | 0.50x | ZAC6.83 Billion | ZAC3.43 Billion | ▲ +54.4% |
| 2020 | 0.33x | ZAC8.26 Billion | ZAC2.69 Billion | ▼ -45.4% |
| 2019 | 0.60x | ZAC6.00 Billion | ZAC3.58 Billion | ▼ -49.1% |
| 2018 | 1.17x | ZAC7.02 Billion | ZAC8.23 Billion | ▲ +193.1% |
| 2017 | 0.40x | ZAC6.50 Billion | ZAC2.60 Billion | ▼ -54.3% |
| 2016 | 0.88x | ZAC3.20 Billion | ZAC2.80 Billion | ▲ +75.1% |
| 2015 | 0.50x | ZAC4.84 Billion | ZAC2.42 Billion | ▼ -5.6% |
| 2014 | 0.53x | ZAC3.84 Billion | ZAC2.03 Billion | ▼ -51.2% |
| 2013 | 1.08x | ZAC3.99 Billion | ZAC4.32 Billion | ▲ +20.4% |
| 2012 | 0.90x | ZAC2.91 Billion | ZAC2.62 Billion | ▲ +162.1% |
| 2011 | 0.34x | ZAC2.45 Billion | ZAC840.20 Million | ▼ -46.0% |
| 2010 | 0.64x | ZAC2.03 Billion | ZAC1.29 Billion | ▼ -79.0% |
| 2009 | 3.02x | ZAC1.29 Billion | ZAC3.91 Billion | ▲ +261.7% |
| 2008 | 0.84x | ZAC652.38 Million | ZAC545.32 Million | ▲ +37.1% |
| 2007 | 0.61x | ZAC708.56 Million | ZAC431.95 Million | ▼ -20.1% |
| 2006 | 0.76x | ZAC402.21 Million | ZAC307.02 Million | ▲ +191.2% |
| 2005 | 0.26x | ZAC638.20 Million | ZAC167.26 Million | ▼ -45.0% |
| 2004 | 0.48x | ZAC498.74 Million | ZAC237.75 Million | ▼ -29.6% |
| 2003 | 0.68x | ZAC385.95 Million | ZAC261.27 Million | — |